RxDoctor Payments DataLook up a doctor →

Naveen Kella, MD

Urology · San Antonio, TXNPI 1154301182

Payments from drug & device makers

$1,044,114in general payments, 2019–2025

Across 763 payments — averaging $1368.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$453K
  • Olympus Corporation Of The Americas$336K
  • Bayer$143K
  • Bluewind Medical$31K
  • Telix Pharmaceuticals$23K
  • Profound Medical Corp.$12K
  • plus $45K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sumitomo Pharma America, Inc.97$453,327
Olympus Corporation Of The Americas22$336,267
Bayer17$143,289
Bluewind Medical14$30,743
Telix Pharmaceuticals42$22,968
Profound Medical Corp.23$12,165
Intuitive Surgical19$11,836
Olympus America Inc.26$10,162
Acerus Pharmaceuticals Corporation33$6,938
Boston Scientific28$3,012
Johnson & Johnson(2 entities)75$2,438
Neotract Inc.10$796
Angiodynamics, Inc.8$762
Astellas Pharma US Inc34$725
Pfizer33$684
Antares Pharma, Inc.26$593
Procept Biorobotics Corporation7$465
Teleflex LLC10$429
Myovant Sciences Inc.21$422
Novartis15$375
Dendreon Pharmaceuticals LLC10$367
Blue Earth Diagnostics8$341
Myriad Genetic Laboratories, Inc.11$269
Ferring Pharmaceuticals Inc.13$253
Urogen Pharma, Inc.8$230
Philips North America LLC2$229
Endo Pharmaceuticals Inc.13$228
Medtronic(2 entities)6$202
Agiliti Surgical, Inc.1$187
AstraZeneca4$176
Foundation Medicine, Inc.5$176
Urovant Sciences Inc9$170
Laborie Medical Technologies Corp.5$164
Clarus Therapeutics Inc.3$153
180 Medical, Inc.6$146
Astellas Pharma Global Development1$145
Merck7$139
Biotissue Holdings Inc.8$134
Progenics Pharmaceuticals, Inc.5$133
Siemens Medical Solutions USA, Inc.1$110
Tolmar, Inc.5$109
Canon Medical Systems USA, Inc.1$100
Coloplast2$99
Halozyme Inc4$79
Sun Pharmaceutical Industries Inc.4$79
Menarini Silicon Biosystems, Inc.3$72
Accord Healthcare, Inc.3$67
Endo USA, Inc.3$66
EDAP Technomed Inc3$63
Uroviu Corporation1$62
Insightec,inc1$62
Clinical Laserthermia Systems Americas Inc.2$60
Tolmar Pharmaceuticals, Inc.3$55
Zyla Life Sciences, Inc.4$54
AbbVie3$52
Travere Therapeutics, Inc.3$50
Smith+Nephew3$49
Immunitybio, Inc.2$48
Novo Nordisk3$47
Amgen3$46

How this compares

$1,044,114 in reported general payments places this provider in the 95th percentile of 878 urology providers in Texas.

See all urology providers in Texas →

Medicare billing

Part B allowed, 2024
$384,673
Medicare patients
857
Services billed
5,348

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →